Eurofins CDMO
Planegg, DE · San Diego, CA
No confirmed program data — ClinicalTrials.gov verification pending
· Last scored 2026-09-07
81.6
Signal Score
✓ FDA Inspections (5)
○ Clinical Trials
○ SEC Filings
✓ Press (8)
○ EMA GMP
○ MHRA GMP
Quick Facts: Eurofins CDMO
- Signal Score
- 81.6/100 (as of 2026-09-07)
- Quality Compliance
- 100.0/100
- Headquarters
- Planegg, DE · San Diego, CA
- Modalities
- Biologics, Cell Therapy
- Active Programs
- Data pending
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About Eurofins CDMO
Pure-play CDMO.
Signal Score & Pillar Breakdown
Scores are being republished.
Scores are being republished under methodology v3.3. The score shown is the last complete v3.2 result, which is also what directory listings and search results show. A pillar breakdown is not shown because the current one is computed under v3.3 and would not explain a v3.2 score. Regulatory evidence below is current.
Quality Compliance
100.0
FDA Inspections5 on record
Warning Letters0
Last InspectionNo Action Indicated (NAI) (2026-05-15)
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesBiologics, Cell Therapy
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
68.0
Profile-based financial assessment
SEC FilingsPrivate company
Capacity
63.0
Profile-based capacity assessment
Recent Press8 articles
Eurofins CDMO FDA Inspection History
2026-05
2025-12
2025-06
2025-03
2024-07
NAI
VAI
OAI
| Date | Site | Type | Observations | Classification |
|---|---|---|---|---|
| 2026-05-15 |
Eurofins Donor & Product Testing, Inc.
Honolulu, Hawaii
Company-level
|
Human Cellular, Tissue, and Gene Therapies | No | No Action Indicated (NAI) |
| 2025-12-12 |
Eurofins Donor & Product Testing, LLC
Philadelphia, Pennsylvania
Facility-linked
|
Human Cellular, Tissue, and Gene Therapies | No | No Action Indicated (NAI) |
| 2025-06-27 |
Eurofins Donor & Product Testing Inc.
Winston Salem, North Carolina
Company-level
|
Human Cellular, Tissue, and Gene Therapies | No | No Action Indicated (NAI) |
| 2025-03-26 |
Eurofins Donor & Product Testing, LLC
Irwindale, California
Facility-linked
|
Human Cellular, Tissue, and Gene Therapies | No | No Action Indicated (NAI) |
| 2024-07-19 |
Eurofins Donor & Product Testing LLC
Centennial, Colorado
Facility-linked
|
Human Cellular, Tissue, and Gene Therapies | No | Voluntary Action Indicated (VAI) |
Source: FDA Data Dashboard · Retrieved Oct 07, 2026
Recent News 8 articles
Dr. Kirithivasan Venkatesan Appointed as Senior Director – Process R&D at Eurofins CDMO India - hrtoday.in
Dr. Kirithivasan Venkatesan Appointed as Senior Director – Process R&D at Eurofins CDMO India hrtoday.in
Eurofins CDMO Alphora Announces Integration of Advanced Continuous Flow Technology in API Manufacturing - BioSpace
Eurofins CDMO Alphora Announces Integration of Advanced Continuous Flow Technology in API Manufacturing BioSpace
Eurofins CDMO Alphora Announces Integration of Advanced Continuous Flow Technology in API Manufacturing - Business Wire
Eurofins CDMO Alphora Announces Integration of Advanced Continuous Flow Technology in API Manufacturing Business Wire
Eurofins CDMO Alphora Announces Integration of Advanced Continuous Flow Technology in API Manufacturing - Bluefield Daily Telegraph
Eurofins CDMO Alphora Announces Integration of Advanced Continuous Flow Technology in API Manufacturing Bluefield Daily Telegraph
Eurofins CDMO Alphora Announces Integration of Advanced Continuous Flow Technology in API Manufacturing - Yahoo Finance
Eurofins CDMO Alphora Announces Integration of Advanced Continuous Flow Technology in API Manufacturing Yahoo Finance
Polyrizon Announces GMP Manufacturing of Clinical Trial Material (CTM) with Eurofins CDMO AmatsiAquitaine S.A.S for Planned U.S. Clinical Study - The Manila Times
Polyrizon Announces GMP Manufacturing of Clinical Trial Material (CTM) with Eurofins CDMO AmatsiAquitaine S.A.S for Planned U.S. Clinical Study The Manila Times
Polyrizon Announces GMP Manufacturing of Clinical Trial Material (CTM) with Eurofins CDMO ... - Caledonian Record
Polyrizon Announces GMP Manufacturing of Clinical Trial Material (CTM) with Eurofins CDMO ... Caledonian Record
Polyrizon Announces GMP Manufacturing of Clinical Trial Material (CTM) with Eurofins CDMO AmatsiAquitaine S.A.S for Planned U.S. Clinical Study - Bitget
Polyrizon Announces GMP Manufacturing of Clinical Trial Material (CTM) with Eurofins CDMO AmatsiAquitaine S.A.S for Planned U.S. Clinical Study Bitget
Frequently Asked Questions About Eurofins CDMO
How many FDA inspections does Eurofins CDMO have on record?
CDMO Signal tracks 5 FDA inspections for Eurofins CDMO, sourced from the FDA inspection database. See the full inspection history above.
Has Eurofins CDMO received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for Eurofins CDMO.
What is Eurofins CDMO's CDMO Signal Score?
Eurofins CDMO has a Signal Score of 82/100, based on quality, operations, financial stability, and capacity data.
Evaluating Eurofins CDMO for a manufacturing program?
Use the free AI matchmaker to compare Eurofins CDMO against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Merck KGaA / MilliporeSigma (CDMO)
Darmstadt, DE · St. Louis, MO
Signal Score: 81.8
mRNA, Biologics, Cell Therapy
Syngene International
Bengaluru, India
Signal Score: 78.5
Biologics, Cell Therapy
Singota Solutions
Bloomington, IN
Signal Score: 59.0
Cell Therapy, Biologics
Pfizer CentreOne
Kalamazoo, MI · McPherson, KS
Signal Score: 91.5
Biologics, mRNA
Bristol Myers Squibb (CGT Mfg)
Bothell, WA · Warren, NJ
Signal Score: 91.1
CAR-T, Cell Therapy